AU2001263775A1 - Glucose dependent release of insulin from glucose sensing insulin derivatives - Google Patents
Glucose dependent release of insulin from glucose sensing insulin derivativesInfo
- Publication number
- AU2001263775A1 AU2001263775A1 AU2001263775A AU6377501A AU2001263775A1 AU 2001263775 A1 AU2001263775 A1 AU 2001263775A1 AU 2001263775 A AU2001263775 A AU 2001263775A AU 6377501 A AU6377501 A AU 6377501A AU 2001263775 A1 AU2001263775 A1 AU 2001263775A1
- Authority
- AU
- Australia
- Prior art keywords
- insulin
- glucose
- dependent release
- derivatives
- sensing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 2
- 239000008103 glucose Substances 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 230000001419 dependent effect Effects 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200000858 | 2000-06-02 | ||
| DKPA200000858 | 2000-06-02 | ||
| PCT/DK2001/000382 WO2001092334A1 (en) | 2000-06-02 | 2001-06-01 | Glucose dependent release of insulin from glucose sensing insulin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001263775A1 true AU2001263775A1 (en) | 2001-12-11 |
Family
ID=8159532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001263775A Abandoned AU2001263775A1 (en) | 2000-06-02 | 2001-06-01 | Glucose dependent release of insulin from glucose sensing insulin derivatives |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1290024A1 (ja) |
| JP (1) | JP2003535106A (ja) |
| AU (1) | AU2001263775A1 (ja) |
| WO (1) | WO2001092334A1 (ja) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101912367A (zh) | 2001-10-30 | 2010-12-15 | 诺瓦提斯公司 | 伊潘立酮和星状聚合物的贮库制剂 |
| US7317000B2 (en) | 2001-12-02 | 2008-01-08 | Novo Nordisk A/S | Glucose-dependent insulins |
| JP2005526009A (ja) * | 2001-12-02 | 2005-09-02 | ノボ ノルディスク アクティーゼルスカブ | 新規グルコース依存性インスリン |
| WO2003105860A1 (en) * | 2002-06-14 | 2003-12-24 | Novo Nordisk A/S | Pharmaceutical use of boronic acids and esters thereof |
| GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
| EP1919286A4 (en) * | 2005-06-10 | 2013-07-10 | Mannatech Inc | SACCHARIDBIOMARKER QUICK TEST |
| WO2009115469A1 (en) | 2008-03-18 | 2009-09-24 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
| KR20110110253A (ko) | 2009-01-28 | 2011-10-06 | 스마트쎌스, 인크. | 결정질 인슐린-접합체 |
| JP2012516339A (ja) | 2009-01-28 | 2012-07-19 | スマートセルズ・インコーポレイテツド | 外因的刺激型制御放出物質体およびその使用 |
| ES2791683T3 (es) | 2009-01-28 | 2020-11-05 | Smartcells Inc | Sistemas a base de conjugados para la administración controlada de fármacos |
| CA2750252A1 (en) | 2009-01-28 | 2010-08-05 | Smartcells, Inc. | Synthetic conjugates and uses thereof |
| EP2408808A4 (en) | 2009-03-20 | 2015-05-06 | Smartcells Inc | TERMINAL-FUNCTIONALIZED CONJUGATES AND THEIR USE |
| US8569231B2 (en) | 2009-03-20 | 2013-10-29 | Smartcells, Inc. | Soluble non-depot insulin conjugates and uses thereof |
| EP2448962B1 (en) | 2009-06-30 | 2016-10-19 | Novo Nordisk A/S | Insulin derivatives |
| AU2011282977A1 (en) | 2010-07-28 | 2013-02-21 | Smartcells, Inc. | Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| CA2805902A1 (en) | 2010-07-28 | 2012-02-02 | Smartcells, Inc. | Recombinant lectins, binding-site modified lectins and uses thereof |
| EP2598527A4 (en) | 2010-07-28 | 2014-01-08 | Smartcells Inc | RECOMBINANT EXPRESSED INSULIN POLYPEPTIDES AND APPLICATIONS THEREOF |
| WO2014093696A2 (en) * | 2012-12-12 | 2014-06-19 | Massachusetts Institute Of Technology | Insulin derivatives for diabetes treatment |
| JP6364067B2 (ja) | 2013-04-05 | 2018-07-25 | ノボ・ノルデイスク・エー／エス | 薬剤送達装置の投与記録装置 |
| CA2924743A1 (en) | 2013-10-04 | 2015-04-09 | Merck Sharp & Dohme Corp. | Glucose-responsive insulin conjugates |
| WO2016149222A2 (en) * | 2015-03-13 | 2016-09-22 | Case Western Reserve University | Insulin analogues containing a glucose-regulated conformational switch |
| CN105954526B (zh) * | 2016-04-26 | 2017-10-10 | 南华大学 | 一种胰岛素的酶免疫测定方法 |
| KR20190015413A (ko) | 2016-06-02 | 2019-02-13 | 사노피 | 글루코오스 감지 단백질에 결합할 수 있는 모이어티 및 약제의 접합체 |
| HRP20221324T1 (hr) | 2016-12-16 | 2022-12-23 | Novo Nordisk A/S | Farmaceutski pripravci koji sadrže inzulin |
| CN107320733A (zh) * | 2017-07-01 | 2017-11-07 | 台州学院 | 一种生理条件下糖响应胰岛素载体的制备方法 |
| CN117624207A (zh) | 2017-11-09 | 2024-03-01 | 诺和诺德股份有限公司 | 葡萄糖敏感性白蛋白结合衍生物 |
| KR20200095507A (ko) | 2017-12-01 | 2020-08-10 | 사노피 | 글루코오스 감지 단백질에 결합할 수 있는 모이어티 및 약제의 신규 접합체 |
| JP2022543586A (ja) * | 2019-07-31 | 2022-10-13 | サーマリン インコーポレイテッド | グルコース調節型立体配座スイッチを有するインスリン類似体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU628674B2 (en) * | 1989-10-19 | 1992-09-17 | Nippon Oil And Fats Company, Limited | Polymer complexes of a sugar response type |
-
2001
- 2001-06-01 AU AU2001263775A patent/AU2001263775A1/en not_active Abandoned
- 2001-06-01 EP EP01938005A patent/EP1290024A1/en not_active Withdrawn
- 2001-06-01 JP JP2002500945A patent/JP2003535106A/ja not_active Withdrawn
- 2001-06-01 WO PCT/DK2001/000382 patent/WO2001092334A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP1290024A1 (en) | 2003-03-12 |
| WO2001092334A1 (en) | 2001-12-06 |
| JP2003535106A (ja) | 2003-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001263775A1 (en) | Glucose dependent release of insulin from glucose sensing insulin derivatives | |
| AU2002349295A1 (en) | Glucose dependant release of insulin from glucose sensing insulin derivatives | |
| AU7830400A (en) | Synthesis of insulin derivatives | |
| AU4063200A (en) | Pressure sensing cannula | |
| AU2001235691A1 (en) | Use of paullone derivatives for making medicines | |
| AU2001239304A1 (en) | Implantable analyte sensor | |
| AU2001260130A1 (en) | Implantable analyte sensor | |
| AU2002300341A1 (en) | Sensor Release for a Blood Glucose Sensor Dispensing Instrument | |
| AU2001259656A1 (en) | Implantable sensor | |
| AU2001251339A1 (en) | Optically based transcutaneous blood gas sensor | |
| AU2001255319A1 (en) | Infrared atr glucose measurement system | |
| AU7355900A (en) | Oximeter sensor with functional liner | |
| AU2001241008A1 (en) | Object tracking using a single sensor or a pair of sensors | |
| AU2001235621A1 (en) | Gyroscopic sensor | |
| AU2002214006A1 (en) | Drugs for diabetes | |
| AU2177001A (en) | Use of indirubine derivatives for making medicines | |
| AU2001278694A1 (en) | Avermectin derivatives | |
| AU2001238346A1 (en) | Modification of biopolymers for improved drug delivery | |
| AU4213299A (en) | Controlled release of substances | |
| AU2002232468A1 (en) | Pharmaceutical heterocyclic compounds | |
| AU2001232948A1 (en) | Controlled release of drugs | |
| EP1144693A3 (en) | Detection of anti-hepatitis b drug resistance | |
| AU4303700A (en) | 6-(((aryl and heteroaryl)oxy) methyl)naphthalene -2-carboximidamide derivatives,preparation and therapeutic application thereof | |
| EP1277840B8 (en) | Drug sensitivity measuring method | |
| AU5848600A (en) | Glass-mounted sensor |